backgroundth
liver
contain
macrophag
myeloid
dendrit
cell
mdc
critic
regul
hepat
inflamm
hepat
macrophag
mdc
deriv
monocyt
recruit
blood
via
poorli
understood
interact
hepat
sinusoid
endotheli
cell
hsec
human
monocyt
believ
contain
precursor
popul
tissu
macrophag
mdc
resultsw
report
cell
local
area
activ
inflamm
fibrosi
chronic
inflammatori
liver
diseas
uniqu
combin
cell
surfac
receptor
promot
transendotheli
migrat
monocyt
human
hsec
physiolog
flow
cx
activ
domin
pertussissensit
mechan
control
transendotheli
migrat
flow
express
cx
ligand
cx
increas
hepat
sinusoid
chronic
inflammatori
liver
diseas
exposur
monocyt
immobil
purifi
cx
trigger
integrinmedi
adhes
induc
develop
migratori
phenotyp
follow
transmigr
exposur
solubl
cx
monocyt
rapidli
transient
lost
express
cx
adhes
transmigr
across
hsec
flow
also
depend
vascular
adhes
hsec
conclusionsour
data
suggest
monocyt
recruit
combin
adhes
signal
involv
cx
mediat
integrinactiv
thu
novel
combin
surfac
molecul
includ
cx
promot
recruit
monocyt
liver
allow
local
site
chronic
inflamm
fibrosi
author
contribut
equal
work
author
contribut
aa
smc
lab
work
help
mb
el
ra
cjw
assist
design
studi
aa
wrote
first
draft
dha
cjw
pfl
help
flow
base
adhes
assay
dha
supervis
work
nih
public
access
liver
contain
bonemarrow
deriv
myeloid
dc
mdc
macrophag
kupffer
cell
recruit
blood
via
hepat
sinusoid
act
immun
sentinel
detect
coordin
respons
invad
pathogen
antigen
enter
liver
via
portal
basal
condit
cell
replenish
recruit
precursor
blood
increas
inflamm
exact
natur
precursor
cell
unclear
like
resid
within
circul
monocyt
mdc
aris
bone
marrowderiv
progenitor
within
monocyt
sever
popul
precursor
propos
includ
lineag
neg
monocyt
human
human
monocyt
display
heterogen
defin
express
chemokin
receptor
adhes
molecul
subset
express
high
level
chemokin
receptor
cx
believ
give
rise
dc
potent
antigenpres
inflammatori
tissu
furthermor
transendotheli
migrat
monocyt
vitro
induc
differenti
function
dc
suggest
recruit
may
shape
subsequ
integr
mdc
function
capac
traffic
one
anatom
compart
anoth
liver
involv
pathway
travers
space
diss
take
cell
along
hepat
sinusoid
portal
tract
recruit
precursor
mdc
blood
tissu
across
endothelium
poorli
mous
precursor
mdc
enter
inflam
skin
use
pselectin
eselectin
chemokin
receptor
littl
known
hepat
recruit
via
sinusoid
vascular
bed
recruit
neutrophil
lymphocyt
liver
involv
distinct
adhes
hypothesis
uniqu
combin
molecul
might
regul
monocyt
recruit
report
recruit
human
monocyt
inflam
liver
involv
uniqu
combin
adhes
molecul
interact
mediat
chemokin
cx
critic
import
liver
tissu
obtain
liver
remov
transplant
queen
elizabeth
hospit
patient
alcohol
liver
diseas
primari
biliari
cirrhosi
primari
scleros
cholang
autoimmun
hepat
peripher
blood
obtain
healthi
volunt
liver
transplant
recipi
sampl
collect
inform
consent
follow
local
ethic
committe
approv
solubl
cx
antichemokin
receptor
mab
except
anticx
obtain
r
system
europ
use
recommend
concentr
tabl
cryostat
section
airdri
polyllysin
treat
slide
acetonefix
stain
section
preincub
hors
serum
vector
laboratori
peterborough
uk
tb
prior
mous
antihuman
mab
cx
nh
control
section
incub
isotypematch
control
mab
antibodi
bind
assess
use
immpress
peroxidis
visualis
novar
chromogen
vector
laboratori
section
counterstain
haematoxylin
total
rna
extract
human
liver
use
rneasi
qiagen
uk
dnase
treatment
rnase
free
dnase
qiagen
extract
rna
transcrib
cdna
use
iscript
cdna
biorad
hercul
ca
elut
rna
cdna
measur
nanodrop
thermofish
scientif
express
human
cx
mrna
quantifi
use
taqman
fluorogen
assay
genespecif
probe
abi
prism
detector
threshold
cycl
ct
valu
target
gene
normal
gapdh
differenti
express
level
calcul
use
blood
mononuclear
cell
isol
use
lympholyt
cedarlan
laboratori
burlington
canada
resuspend
label
medium
edta
fc
receptor
block
mous
immunoglobulin
directli
conjug
mab
ad
cell
resuspend
label
medium
analyz
use
cyan
flow
cytomet
beckman
coulter
buck
uk
cell
maintain
ice
throughout
except
demonstr
cx
internalis
perform
optiprep
densiti
gradient
centrifug
produc
pure
monocyt
monocyt
isol
enrich
popul
highspe
flow
cytometr
sort
fc
receptor
enrich
monocyt
block
normal
mous
ig
directli
conjug
mab
ad
ice
min
wash
resuspend
label
medium
sort
use
moflo
cell
sorter
beckmancoult
three
gate
set
sort
one
exclud
doublet
event
one
includ
monocyt
exclud
cellsdebri
one
includ
cell
produc
popul
pure
monocyt
hsec
isol
use
publish
method
substitut
nycodenz
axi
shield
discontinu
metrizamid
densitygradi
centrifug
fresh
liver
minc
incub
collagenas
iv
sigma
pool
uk
min
filter
nylon
mesh
dilut
pb
layer
nycodenz
pb
centrifug
cell
interfac
collect
wash
cholangiocyt
remov
neg
immunomagnet
select
endotheli
cell
posit
select
use
antibodi
cultur
human
endotheli
basal
media
plu
human
serum
hgf
vegf
ngml
peprotech
uk
use
within
four
passag
protocol
develop
isol
suffici
cell
either
normal
diseas
human
liver
use
function
assay
rat
suggest
use
isol
sinusoid
cell
cellsurfac
absent
quiescent
sinusoid
endothelium
use
gener
cell
low
frequenc
howev
find
human
sinusoid
endotheli
cell
express
cell
surfac
albeit
lower
level
vascular
endothelium
find
consist
publish
confirm
cell
human
liver
sinusoid
phenotyp
demonstr
express
sever
receptor
present
sinusoid
vascular
endothelium
includ
hyaluronan
receptor
ctype
lectin
lsectin
mannos
receptor
cell
thu
uniqu
sinusoid
phenotyp
also
express
increas
express
respons
cytokin
phenotyp
correspond
activ
sinusoid
endothelium
vivo
consist
distinct
phenotyp
previous
report
function
signal
respons
cell
differ
seen
vascular
endotheli
relev
vitro
studi
use
hsec
situat
vivo
illustr
fact
mani
vitro
find
hsec
subsequ
confirm
other
use
vivo
model
exampl
involv
lymphocyt
recruit
via
hepat
sinusoid
first
propos
use
hsec
subsequ
confirm
other
use
rat
mous
model
thu
hsec
cultur
passag
maintain
express
cell
surfac
receptor
defin
sinusoid
origin
b
allow
interact
leukocyt
flowbas
assay
thu
believ
cell
despit
lose
fenestr
passag
cultur
appropri
model
leukocyt
recruit
liver
particularli
process
usual
occur
damag
inflam
sinusoid
refer
human
liver
sinusoid
endotheli
cell
hsec
flowbas
adhes
assay
conduct
hsec
grown
confluenc
glass
capillari
stimul
r
system
connect
flowbas
system
experi
solubl
protein
coat
onto
slide
recombin
cx
ngml
r
system
recombin
gift
david
smith
bioti
therapi
recombin
r
system
human
albumin
sigma
pool
uk
monocyt
perfus
capillari
wall
shear
stress
mimic
flow
hepat
sinusoid
pa
adher
cell
visual
phasecontrast
microscopi
roll
adher
phase
bright
transmigr
cell
phase
dark
quantifi
offlin
digit
analysi
number
adher
cell
calcul
mm
cell
perfus
adhes
block
use
r
system
anticx
mbl
gift
david
smith
bioti
therapi
pertussi
toxin
ptx
sigma
uk
block
reagent
incub
hsec
monocyt
minut
wash
assay
falcon
transwel
wellsplat
pore
bectondickinson
coat
upper
membran
surfac
rattail
collagen
seed
hsec
grown
confluenc
stimul
monocyt
ad
top
chamber
hour
rins
top
well
remov
nonadher
cell
transmigr
cell
harvest
bottom
well
wash
pbsbsa
analyz
flow
cytometri
hepat
mdc
isol
freshli
explant
liver
use
mechan
densiti
gradient
separ
hepat
mdc
identifi
flow
cytometri
cell
within
monocyt
cloud
express
high
level
hladr
cx
engag
use
purifi
recombin
cx
activ
mncl
use
posit
control
antibodi
recogn
conform
depend
epitop
use
detect
activ
incub
primari
mab
isotypematch
control
done
min
room
temperatur
cx
engag
fitcconjug
secondari
antibodi
goat
antimous
goat
antirat
use
detect
bind
flow
cytometri
data
analyz
use
twoway
anova
tukey
post
test
graphpad
instat
graphpad
softwar
san
diego
ca
detect
three
subset
monocyt
human
blood
figur
monocyt
human
blood
express
low
level
two
molecul
associ
lymph
node
entri
chemokin
receptor
express
cell
subset
limit
chemokin
receptor
repertoir
cell
inflammatori
phenotyp
cx
express
similar
level
three
subset
cx
normal
human
liver
larg
limit
bile
duct
wherea
diseas
liver
also
detect
sinusoid
fig
increas
express
inflammatori
diseas
confirm
realtim
qpcr
fig
normal
liver
cell
detect
throughout
parenchyma
consist
kupffer
cell
mononuclear
cell
within
portal
tract
diseas
liver
cell
increas
area
inflamm
includ
fibrot
septa
expand
portal
tract
seen
close
associ
bile
duct
cirrhot
liver
rel
loss
cell
within
regen
nodul
associ
increas
number
site
inflammationfibrosi
fig
monocyt
purifi
peripher
blood
describ
perfus
microslid
contain
confluent
hsec
stimul
number
monocyt
bind
hsec
determin
fig
adhes
subclassifi
cell
becam
activ
chang
shape
migrat
across
endotheli
monolay
phase
dark
fig
sever
inhibitor
effect
adhes
migrat
hsec
includ
antibodi
pand
eselectin
data
shown
confirm
lack
involv
selectin
vascular
heterotrimer
protein
involv
chemokin
receptor
signal
inhibit
use
ptx
preincub
monocyt
ptx
caus
decreas
total
adher
cell
virtual
abolish
transmigr
demonstr
lack
phasedark
monocyt
beneath
endothelium
figur
cell
express
high
level
cx
look
inhibit
receptor
use
antibodi
desensitis
prior
exposur
ligand
cx
approach
reduc
transmigr
normalis
number
adher
cell
similar
level
seen
ptx
treatment
fig
suggest
cx
domin
gpc
receptor
involv
total
adhes
effici
inhibit
anticx
antibodi
ptx
suggest
adhes
gpcindepend
consist
previou
studi
show
transmembran
cx
support
leucocyt
adhes
directli
fig
antibodi
combin
decreas
total
adher
cell
fig
wherea
alon
effect
data
shown
inhibit
hsec
antibodi
immedi
flowbas
adhes
assay
reduc
proport
cell
undergo
transendotheli
migrat
fig
investig
role
cx
adhes
migrat
flow
studi
combin
purifi
protein
microslid
coat
solubl
cx
cx
alon
data
shown
abl
support
monocyt
adhes
adher
cell
approxim
chang
shape
develop
migratori
phenotyp
coimmobilis
cx
total
number
adher
cell
increas
proport
undergo
shapechang
increas
fig
chang
seen
level
adhes
shapechang
irrelev
chemokin
coimmobilis
adhes
shapechang
associ
activ
integrin
fig
demonstr
increas
bind
mab
recognis
conformationdepend
activ
site
follow
exposur
monocyt
solubl
cx
thu
engag
cx
immobil
cx
induc
downstream
activ
integrin
express
cx
monocyt
follow
transmigr
studi
transwel
hsec
cultur
membran
insert
monocyt
appli
top
chamber
cell
migrat
remov
bottom
chamber
level
cx
determin
follow
transmigr
hsec
express
cx
decreas
monocyt
figur
preincub
monocyt
solubl
cx
reduc
surfac
cx
reexpress
one
hour
remov
solubl
cx
due
receptor
mask
express
remain
detect
experi
repeat
fig
match
blood
liver
tissu
patient
undergo
liver
transplant
use
compar
express
cx
mdc
freshli
isol
liver
tissu
monocyt
patient
blood
figur
demonstr
intermedi
level
cx
monocyt
blood
whera
hepat
mdc
defin
express
mhc
class
ii
show
heterogen
cx
express
cell
express
high
level
wherea
other
level
compar
seen
blood
monocyt
liver
contain
mdc
tissu
macrophag
regul
local
immun
respons
basal
condit
cell
continu
replenish
recruit
precursor
blood
increas
inflamm
show
cell
redistribut
chronic
inflam
liver
detect
site
inflamm
fibrosi
fig
consist
studi
suggest
cell
precursor
inflammatori
tissu
macrophag
inflammatori
human
cell
undergo
differenti
dc
migrat
dc
present
human
lead
us
investig
molecul
involv
monocyt
recruit
blood
liver
via
hepat
sinusoid
use
flowbas
adhes
assay
incorpor
primari
human
hepat
sinusoid
endothelium
model
liver
show
human
monocyt
express
cell
adhes
molecul
chemokin
receptor
could
promot
recruit
blood
includ
cx
demonstr
use
combin
cx
arrest
hsec
flow
combin
cx
undergo
transendotheli
migrat
thu
show
first
time
involv
dc
precursor
recruit
peripher
tissu
defin
role
play
cx
transmigr
human
endothelium
flow
cx
express
uniformli
high
level
monocyt
fig
domin
chemokin
receptor
involv
fig
antibodi
cx
inhibit
adhes
transmigr
across
hsec
cx
transmembran
chemokin
support
adhes
independ
signal
gpc
receptor
consist
find
adhes
cell
hsec
effici
inhibit
anticx
antibodi
ptx
howev
transmigr
clearli
depend
signal
via
cx
almost
complet
prevent
ptx
investig
role
cx
studi
adhes
flow
recombin
protein
system
cx
unabl
support
adhes
facilit
adhes
coimmobilis
activ
integrin
recombin
cx
use
experi
fulli
glycosyl
gpcindepend
adhes
mediat
mucin
domain
decor
transmembran
cx
may
explain
inabl
directli
support
adhes
cx
previous
shown
support
monocyt
adhes
huvec
observ
extend
role
liverspecif
vascular
bed
implic
transendotheli
migrat
addit
adhes
cx
express
human
liver
present
studi
confirm
express
bile
duct
show
induc
express
chronic
inflammatori
liver
diseas
sinusoid
could
act
promot
recruit
cx
cell
blood
fig
monocyt
blood
show
homogen
intermedi
level
cx
wherea
mdc
isol
liver
includ
cx
high
cell
popul
express
level
compar
blood
monocyt
monocyt
lost
cx
surfac
express
process
transmigr
consequ
receptor
engag
cx
exposur
solubl
cx
vitro
result
profound
transient
loss
cellsurfac
cx
could
explain
prior
exposur
solubl
cx
prevent
transendotheli
migrat
similar
effect
report
chemokin
thu
cx
must
appropri
retain
present
endothelium
function
effici
reexpress
cx
cell
recruit
liver
parenchyma
could
import
onward
migrat
area
portal
lobular
inflamm
cx
also
strongli
express
figur
addit
cx
involv
monocyt
transendotheli
migrat
flow
belong
expand
famili
ectoenzym
involv
cellular
present
liver
sinusoid
endothelium
implic
lymphocyt
recruit
human
solubl
detect
high
level
serum
patient
chronic
liver
diseas
inflammatori
condit
rheumatoid
mediat
sialic
acid
depend
tether
transendotheli
migrat
lymphocyt
sinusoid
first
time
implic
monocyt
transendotheli
migrat
although
reduc
monocyt
recruit
inflammatori
site
report
mice
found
involv
adhes
transendotheli
migrat
combin
immobilis
cx
protein
fail
support
signific
level
adhes
suggest
oper
conjunct
receptor
mediat
transendotheli
migrat
consist
data
show
enzymat
activ
modul
express
adhes
fig
find
add
evolv
bodi
literatur
implic
import
molecul
leucocyt
transmigr
across
hepat
sinusoid
endothelium
vitro
vivo
provid
evid
sinusoid
bed
use
distinct
combin
molecul
recruit
leucocyt
liver
role
transendotheli
migrat
particularli
interest
monocyt
transendotheli
migrat
across
endothelium
involv
jam
present
tight
lack
hepat
sinusoid
could
explain
domin
role
vascular
bed
recruit
monocyt
liver
major
factor
determin
outcom
hepat
inflamm
inflammatori
monocyt
drive
liver
injuri
myeloid
dc
play
critic
role
regul
immun
respons
injuri
infect
macrophag
central
resolut
hepat
inflamm
demonstr
cx
implic
recruit
monocyt
across
inflam
hepat
endothelium
cell
local
area
inflamm
fibrosi
import
implic
pathogenesi
hepat
inflamm
design
therapi
modul
monocyt
recruit
liver
diseas
recent
appreci
inhibit
small
molecul
enzym
inhibitor
open
excit
therapeut
approach
target
receptor
thu
critic
understand
leucocyt
reli
entri
tissu
outcom
inhibit
receptor
monocyt
analyz
express
cell
adhes
molecul
chemokin
receptor
surfac
molecul
cx
express
level
popul
b
e
compar
monocyt
molecul
express
lower
level
monocyt
c
f
note
popul
slightli
higher
level
monocyt
consist
put
role
mdc
precursor
complet
character
chemokin
receptor
express
three
popul
monocyt
h
defin
express
normal
diseas
human
liver
tissu
analys
express
cx
total
rna
analys
express
cx
mrna
qpcr
demonstr
increas
primari
biliari
cirrhosi
increas
alcohol
liver
diseas
ald
autoimmun
hepat
aih
compar
noninflam
liver
similar
increas
detect
primari
scleros
cholang
psc
though
reach
signific
valu
rel
normal
liver
nl
n
sem
p
p
immunohistochem
analysi
normal
liver
b
reveal
express
cx
limit
biliari
structur
arrow
whilst
diseas
liver
express
persist
bile
duct
increas
sinusoid
c
local
cell
assess
normal
diseas
human
liver
tissu
immunohistochemistri
normal
liver
cell
locat
throughout
parenchyma
portal
tract
pt
diseas
liver
b
associ
inflammatori
infiltr
fibrot
septa
larg
absent
regen
nodul
rn
monocyt
adher
transmigr
across
hsec
flow
pretreat
monocyt
ptx
hsec
block
antibodi
cx
result
signific
decreas
total
number
cell
adher
endotheli
monolay
flow
quantifi
number
adher
cell
subsequ
went
transmigr
hsec
monolay
transmigr
cell
migrat
beneath
endotheli
monolay
phase
dark
easili
distinguish
phase
bright
cell
adher
surfac
monolay
number
adher
cell
transmigr
significantli
reduc
presenc
block
antibodi
virtual
abolish
treatment
hsec
anticx
cx
treatment
induc
adhes
shape
chang
monocyt
monocyt
bound
immobilis
microslid
less
cell
undergo
shape
chang
combin
immobilis
cx
support
higher
number
adher
cell
major
show
morpholog
chang
consist
migratori
phenotyp
furthermor
analysi
activ
integrin
monocyt
demonstr
near
doubl
median
channel
fluoresc
follow
exposur
cx
b
flow
data
repres
mean
sem
three
experi
cytometri
data
repres
three
repeat
p
comparison
cx
express
monocyt
prior
transmigr
across
hsec
vitro
purifi
monocyt
appli
top
chamber
transwel
coat
hsec
stimul
transmigr
cell
collect
compar
preemigr
cell
cx
express
transmigr
cell
exhibit
nearcomplet
loss
cx
express
addit
loss
express
could
recapitul
incub
monocyt
cx
prior
antibodi
label
b
preincub
complet
diminish
receptor
express
recov
follow
addit
rest
follow
remov
exogen
cx
confirm
due
receptor
mask
repeat
experi
ice
receptor
loss
follow
engag
cx
may
contribut
retain
precursor
dc
liver
promot
matur
liverspecif
mdc
repres
flow
cytometr
profil
three
replic
experi
comparison
express
cx
monocyt
mdc
human
liver
peripher
blood
monocyt
taken
patient
undergo
liver
transplant
end
stage
liver
diseas
exhibit
intermedi
level
express
cx
similar
level
express
note
healthi
donor
fig
mdc
repres
matur
form
dc
precursor
transmigr
across
hsec
isol
liver
patient
hour
later
identifi
flow
cytometri
cell
within
monocyt
cloud
express
high
level
mhc
class
ii
mdc
exhibit
either
high
low
express
cx
compar
intermedi
level
express
monocyt
suggest
microenviron
liver
may
regul
express
cx
repres
flow
cytometr
profil
three
replic
experi
